Karnataka
News Category
Lantern Pharma Receives U.S. Patent Allowance for Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to identify patients with ovarian, liver, kidney, ...
July 23, 2026Read the full article →
Formycon and OneSource Specialty Pharma Forge Strategic Biosimilar Manufacturing Partnership
Formycon AG and OneSource Specialty Pharma announce a strategic manufacturing partnership to leverage OneSource's Indian facility for cost-efficient b...
July 14, 2026Read the full article →
Lantern Pharma Launches ZetaOmics, an AI-Powered Computational Biology Platform for Multi-Omic Analysis
Lantern Pharma's launch of ZetaOmics brings autonomous bioinformatics to cancer research, potentially accelerating drug development and expanding its ...
July 8, 2026Read the full article →